Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Germany”

HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of LifeRecruiting
NCT05373264Phase 3Updated Aug 14, 2026
Sponsor: University Medical Center Groningen
ADPKD
Belgium, France, Germany, Netherlands, Spain +1 more
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric ParticipantsRecruiting
NCT05835310Phase 3Updated Aug 14, 2026
Sponsor: AstraZeneca
Systemic Lupus Erythematosus
United States, Argentina, Brazil, Canada, China +12 more
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused Etentamig (ABBV-383) in Combination With Anti-Cancer Regimens for the Treatment of Adult Participants With Relapsed/Refractory Multiple MyelomaActive Not Recruiting
NCT05259839Phase 1Updated Aug 14, 2026
Sponsor: AbbVie
Relapsed/Refractory Multiple Myeloma
United States, Australia, Germany, Italy, Japan +2 more
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian CancerRecruiting
NCT06072781Phase 3Updated Aug 14, 2026
Sponsor: Verastem, Inc.
Low Grade Serous Ovarian Cancer
United States, Australia, Belgium, Canada, Denmark +11 more
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe DiseaseRecruiting
NCT06679140Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
COVID-19 SARS-CoV-2 Infection
United States, Argentina, Belgium, Brazil, Bulgaria +14 more
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)Recruiting
NCT07179380Phase 3Updated Aug 14, 2026
Sponsor: Insmed Incorporated
Pulmonary Hypertension · Interstitial Lung Disease
United States, Argentina, Australia, Austria, Belgium +22 more
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other TreatmentsRecruiting
NCT05020236Phase 3Updated Aug 14, 2026
Sponsor: Pfizer
Multiple Myeloma
United States, Argentina, Australia, Austria, Belgium +21 more
A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic DermatitisRecruiting
NCT07277660Phase 2Updated Aug 14, 2026
Sponsor: UCB Biopharma SRL
Atopic Dermatitis
United States, Bulgaria, Canada, Czechia, Germany +4 more
A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALLRecruiting
NCT05748171Phase 2Updated Aug 14, 2026
Sponsor: Pfizer
ACUTE LYMPHOBLASTIC LEUKEMIA
Austria, Belgium, Czechia, Denmark, Finland +11 more
Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative TreatmentActive Not Recruiting
NCT03847428Phase 3Updated Aug 14, 2026
Sponsor: AstraZeneca
Hepatocellular Carcinoma
United States, Australia, Austria, Brazil, Canada +19 more
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCTRecruiting
NCT07764978Phase 3Updated Aug 14, 2026
Sponsor: AstraZeneca
Newly Diagnosed Multiple Myeloma
United States, Australia, Brazil, Canada, Denmark +10 more
A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial SpondyloarthritisActive Not Recruiting
NCT04436640Phase 3Updated Aug 14, 2026
Sponsor: UCB Biopharma SRL
Axial Spondyloarthritis · Ankylosing Spondylitis · r-axSpa · Nr-axSpa
United States, Belgium, Bulgaria, China, Czechia +9 more
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 GangliosidosisRecruiting
NCT07054515Phase 3Updated Aug 14, 2026
Sponsor: Azafaros B.V.
Niemann-Pick Type C Disease · GM1 Gangliosidosis · GM2 Gangliosidosis
United States, Argentina, Australia, Brazil, Canada +12 more
Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Real-Life SettingRecruiting
NCT03342144N/AUpdated Aug 14, 2026
Sponsor: AbbVie
Chronic Lymphocytic Leukemia (CLL)
Austria, Germany, Switzerland
Alleviant ALLAY-HF StudyRecruiting
NCT05685303NAUpdated Aug 14, 2026
Sponsor: Alleviant Medical, Inc.
Heart Failure
United States, Australia, Austria, Belgium, Bulgaria +9 more
Exercise Training in Patients With Myeloproliferative NeoplasmsRecruiting
NCT07384039NAUpdated Aug 14, 2026
Sponsor: Hannover Medical School
Myeloproliferative Neoplasms (MPN)
Germany
A Study of Mezagitamab in Adults With Kidney Condition Called IgA NephropathyRecruiting
NCT06963827Phase 3Updated Aug 14, 2026
Sponsor: Takeda
Kidney Disease
United States, Argentina, Australia, Austria, Canada +21 more
An Open-label Study (OLE) for Non-responders of VRDN-001-101 and VRDN-001-301Completed
NCT06179875Phase 3Updated Aug 14, 2026
Sponsor: Viridian Therapeutics, Inc.
Thyroid Eye Disease
United States, France, Germany, Netherlands, Poland +3 more
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.Recruiting
NCT05609630Phase 3Updated Aug 14, 2026
Sponsor: AbbVie
Juvenile Idiopathic Arthritis
United States, Argentina, Australia, Austria, Brazil +12 more
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)Recruiting
NCT07007065Phase 3Updated Aug 14, 2026
Sponsor: AbbVie
Neovascular Age-related Macular Degeneration
United States, Austria, Belgium, Bulgaria, Canada +12 more
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)Recruiting
NCT07489495Phase 3Updated Aug 14, 2026
Sponsor: Merck Sharp & Dohme LLC
Carcinoma, Renal Cell
United States, Argentina, Australia, Brazil, Chile +13 more
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)Recruiting
NCT06875310Phase 3Updated Aug 14, 2026
Sponsor: Mirati Therapeutics Inc.
Carcinoma, Non-Small-Cell Lung
United States, Argentina, Australia, Austria, Belgium +30 more
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related ComorbiditiesRecruiting
NCT07743463Phase 3Updated Aug 14, 2026
Sponsor: Ascletis Pharma (China) Co., Limited
Obesity · Overweight · Chronic Weight Management
United States, Canada, Czechia, Germany, Greece +2 more
HomeVent ( Connect) Registry: EU COPD Home NIV RegistryCompleted
NCT02811588N/AUpdated Aug 14, 2026
Sponsor: ResMed
Chronic Obstructive Pulmonary Disease
Germany
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOGAD)Active Not Recruiting
NCT05063162Phase 3Updated Aug 14, 2026
Sponsor: UCB Biopharma SRL
Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)
United States, Australia, Belgium, Brazil, Czechia +15 more

Previous page Next page